Question 1

How many shares of KYTX does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 365,574 shares of KYTX (KYVERNA THERAPEUTICS INC).

Question 2

What is UBS Group AG's KYTX position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's KYTX position is worth $3.3M.

Question 3

Is UBS Group AG buying or selling KYTX?

Accepted Answer

In 2026-Q2, UBS Group AG decreased their KYTX position (-18.7% change in shares).

Question 4

When did UBS Group AG first buy KYTX?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in KYTX in 2024-Q1. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	365,574	-18.7%	$3.3M	0.0%	$8.91	0
2026-Q1	Increased	449,750	+122.4%	$3.9M	0.0%	$8.02	43
2025-Q4	Increased	202,187	+28.4%	$1.9M	0.0%	$9.35	32
2025-Q3	Increased	157,422	+60.4%	$944,532	0.0%	$5.94	36
2025-Q2	Decreased	98,158	-44.8%	$301,345	0.0%	$3.28	0
2025-Q1	Decreased	177,670	-12.7%	$342,903	0.0%	$2.00	0
2024-Q4	Increased	203,403	+2381.7%	$760,727	0.0%	$3.64	40
2024-Q3	Decreased	8,196	-15.0%	$40,078	0.0%	$5.23	0
2024-Q2	Decreased	9,644	-61.3%	$72,330	0.0%	$7.50	0
2024-Q1	New	24,898	-	$618,466	0.0%	$24.84	34

KYTX10 quarters

KYTX
10 quarters